FL3 (flavagline)
FL3 (flavagline) is a synthetic flavagline derivative that has been extensively studied for its potential therapeutic applications in oncology and neurology. It is known for its potent anti-cancer and neuroprotective properties.
Chemistry
FL3 is a synthetic derivative of the natural product rocaglamide, which is a member of the flavagline class of compounds. Flavaglines are a group of compounds isolated from the plant genus Aglaia, known for their diverse biological activities.
Pharmacology
FL3 exhibits potent anti-cancer activity by inhibiting the synthesis of proteins necessary for tumor growth and survival. It acts by binding to the eukaryotic initiation factor 4A (eIF4A), an RNA helicase involved in the initiation of protein synthesis. By inhibiting eIF4A, FL3 disrupts the synthesis of proteins that are critical for cancer cell survival and proliferation.
In addition to its anti-cancer properties, FL3 has also been shown to have neuroprotective effects. It has been found to protect neurons from apoptosis (programmed cell death) induced by various stressors, suggesting potential applications in the treatment of neurodegenerative diseases.
Clinical Applications
The potent anti-cancer and neuroprotective properties of FL3 have led to its investigation as a potential therapeutic agent in a variety of clinical settings. Studies have shown that FL3 has potential therapeutic applications in the treatment of various types of cancer, including breast cancer, prostate cancer, and leukemia. In addition, its neuroprotective effects suggest potential applications in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Safety and Toxicity
As with any potential therapeutic agent, the safety and toxicity of FL3 are important considerations. Preclinical studies have shown that FL3 has a favorable safety profile, with low toxicity observed in animal models. However, further studies are needed to fully assess the safety and potential side effects of FL3 in humans.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD